However, the peri-implant crestal bone change did not differ significantly among the 3 types of implant-abutment connections during the healing phase, loading phase 1, or loading phase 2. This retrospective clinical study reveals that the design of the implant-abutment connection appears to have no significant impact on short-term peri-implant crestal bone change.”
“Gastric bypass surgery

and exenatide therapy represent two relatively new methods in treating morbid VX-770 inhibitor obesity and type 2 diabetes, although there are many differences between them. With the data supported from our hospital, we just want to investigate the differences between bypass surgery and exenatide injection and want to answer the question: Which one is the best? And Why?\n\nData from January 2009 to January 2010 were summarized for comparison at Shengjing hospital, including weight loss, plasma glucose and insulin changes, glycosylated hemoglobin, and the subjective scores of patients themselves. Plasma lipoprotein and serum ions were measured to evaluate the nutrition status.\n\nPatients in the GB group received more weight loss and better glucose control compared with the EX group. At 6 months, feeding insulin level in the GB group was 18.1 +/- 3.2 mU/L, which was much lower than that in the EX group (64.5 +/- 13.2 mU/L, P < 0.01). The Hb1AC level in the GR group was 6.08 +/- 0.56 %, much

lower than that in the EX group (7.19 +/- 0.72 %, P < 0.01). We did not

find any statistical mTOR activation differences in lipoprotein, plasma ions, and subjective scores between the GB and EX groups.\n\nGastric bypass surgery is better in weight control and in the remission Dorsomorphin of insulin resistance compared with exenatide therapy. Both methods were safe and have no nutritional disorder in early stage, although the transferring in the GB group was higher than the EX group. The subjective scores from both groups declared that both methods could be accepted by patients.”
“Objectives: The aims of this study were to gain a better understanding of the motivations of pregnant women utilizing moxibustion for breech presentation and to measure the impact of research results on these patients’ treatment decisions regarding this alternative medicine technique.\n\nDesign: The study involved a statistical analysis of two self-administered questionnaires to 212 women who had previously participated in a randomized clinical trial on the efficacy of moxibustion; in addition, a qualitative thematic content analysis for open-ended questions was also performed.\n\nResults: Most women (69%) reported treating themselves at least once with complementary and alternative medicine (CAM). Higher use of CAM was associated with higher education and Caucasian origin. Pregnancy was associated with a significant reduction in utilization of CAMs.